Minnesota SF 3768: Prescription drug benefit transparency and disclosure requirement

Status: Referred to Commerce and Consumer Protection Finance and Policy (as of 2022-03-07)

State: Minnesota · Session: 2021-2022 · Bill: SF 3768

Subjects: Drugs and Medicine, Health and Health Department, Insurance-Health

Sponsors: Tomassoni, Abeler, Bakk, Hoffman, Newton

View Minnesota SF 3768 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.